SIMILAR PATTERNS OF AMINO ACIDS FOR 3EM4_V_DR7V100_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
5 GLY A  40
ALA A  39
ASP A  38
PRO A 299
ILE A 328
None
0.92A 3em4U-1fobA:
undetectable
3em4U-1fobA:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fxz GLYCININ G1

(Glycine max)
PF00190
(Cupin_1)
5 GLY A  47
ALA A  46
ILE A  14
VAL A 392
ILE A 394
None
0.92A 3em4U-1fxzA:
undetectable
3em4U-1fxzA:
13.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.95A 3em4U-1hvcA:
14.2
3em4U-1hvcA:
47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.62A 3em4U-1hvcA:
14.2
3em4U-1hvcA:
47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.37A 3em4U-1hvcA:
14.2
3em4U-1hvcA:
47.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i41 CYSTATHIONINE
GAMMA-SYNTHASE


(Nicotiana
tabacum)
PF01053
(Cys_Met_Meta_PP)
5 GLY A 251
ALA A 252
ASP A 253
LEU A 221
ILE A 235
None
0.90A 3em4U-1i41A:
undetectable
3em4U-1i41A:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j2b ARCHAEOSINE
TRNA-GUANINE
TRANSGLYCOSYLASE


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF01702
(TGT)
PF14809
(TGT_C1)
PF14810
(TGT_C2)
5 ASP A 535
GLY A 537
ASP A 542
GLY A 449
PRO A 504
None
0.90A 3em4U-1j2bA:
undetectable
3em4U-1j2bA:
11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1llu ALCOHOL
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  42
ILE A  64
GLY A 119
VAL A  36
ILE A  38
None
0.93A 3em4U-1lluA:
undetectable
3em4U-1lluA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q40 MRNA TRANSPORT
REGULATOR MTR2


(Candida
albicans)
PF10429
(Mtr2)
5 ILE A 163
GLY A  43
LEU A  42
VAL A  54
ILE A  52
None
0.88A 3em4U-1q40A:
undetectable
3em4U-1q40A:
17.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
None
0.49A 3em4U-1q9pA:
10.5
3em4U-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
None
0.83A 3em4U-1q9pA:
10.5
3em4U-1q9pA:
89.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rvv RIBOFLAVIN SYNTHASE

(Bacillus
subtilis)
no annotation 6 GLY A  33
ALA A  34
ILE A 112
GLY A 114
VAL A  50
ILE A  17
None
1.45A 3em4U-1rvvA:
undetectable
3em4U-1rvvA:
26.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
0.61A 3em4U-1sivA:
18.8
3em4U-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tjr BX1

(Zea mays)
PF00290
(Trp_syntA)
6 GLY A 307
ALA A 308
ASP A 309
LEU A 276
VAL A 269
ILE A 303
None
1.25A 3em4U-1tjrA:
undetectable
3em4U-1tjrA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
5 GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.71A 3em4U-1to3A:
undetectable
3em4U-1to3A:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yr2 PROLYL
OLIGOPEPTIDASE


(Novosphingobium
capsulatum)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 539
ALA A 538
ASP A 537
GLY A 529
PRO A 475
VAL A 474
None
1.07A 3em4U-1yr2A:
undetectable
3em4U-1yr2A:
8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z7e PROTEIN ARNA

(Escherichia
coli)
PF00551
(Formyl_trans_N)
PF01370
(Epimerase)
PF02911
(Formyl_trans_C)
5 ASP A 368
GLY A 322
LEU A 389
VAL A 380
ILE A 376
ATP  A1001 (-3.3A)
ATP  A1001 ( 3.9A)
None
None
None
0.84A 3em4U-1z7eA:
undetectable
3em4U-1z7eA:
10.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bkl PROLYL ENDOPEPTIDASE

(Myxococcus
xanthus)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 497
ALA A 496
ASP A 495
GLY A 487
PRO A 431
VAL A 430
None
1.09A 3em4U-2bklA:
undetectable
3em4U-2bklA:
10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bll PROTEIN YFBG

(Escherichia
coli)
PF01370
(Epimerase)
5 ASP A 368
GLY A 322
LEU A 389
VAL A 380
ILE A 376
None
0.88A 3em4U-2bllA:
undetectable
3em4U-2bllA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bws XAA-PRO
AMINOPEPTIDASE P


(Escherichia
coli)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 ARG A 221
GLY A 262
ALA A 261
ASP A 260
ILE A 215
None
None
None
MN  A1442 (-2.0A)
None
0.82A 3em4U-2bwsA:
undetectable
3em4U-2bwsA:
14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d1q LUCIFERIN
4-MONOOXYGENASE


(Luciola
cruciata)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 GLY A 318
ALA A 319
ILE A 532
GLY A 527
LEU A 528
AMP  A1001 (-3.5A)
None
None
None
None
0.92A 3em4U-2d1qA:
undetectable
3em4U-2d1qA:
12.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.53A 3em4U-2fmbA:
15.2
3em4U-2fmbA:
33.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h00 METHYLTRANSFERASE 10
DOMAIN CONTAINING
PROTEIN


(Homo sapiens)
PF05971
(Methyltransf_10)
5 GLY A  84
ALA A  85
GLY A  69
VAL A 120
ILE A 118
None
None
None
DTU  A2140 (-4.0A)
None
0.91A 3em4U-2h00A:
undetectable
3em4U-2h00A:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2id0 EXORIBONUCLEASE 2

(Escherichia
coli)
PF00575
(S1)
PF00773
(RNB)
PF08206
(OB_RNB)
6 GLY A 584
ALA A 585
GLY A 546
LEU A 549
VAL A 631
ILE A 638
None
1.41A 3em4U-2id0A:
undetectable
3em4U-2id0A:
10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2np0 BOTULINUM NEUROTOXIN
TYPE B


(Clostridium
botulinum)
PF01742
(Peptidase_M27)
PF07951
(Toxin_R_bind_C)
PF07952
(Toxin_trans)
PF07953
(Toxin_R_bind_N)
5 ARG A 868
ASP A 876
GLY A 881
ALA A 882
ILE A 917
None
0.88A 3em4U-2np0A:
undetectable
3em4U-2np0A:
5.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.28A 3em4U-2rkfA:
20.8
3em4U-2rkfA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ARG A  10
ASP A  37
GLY A  39
ALA A  40
ASP A  41
None
0.85A 3em4U-2rspA:
12.9
3em4U-2rspA:
32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 ARG A 105
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
1.45A 3em4U-2rspA:
12.9
3em4U-2rspA:
32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xuz IRON-UPTAKE
SYSTEM-BINDING
PROTEIN


(Bacillus
subtilis)
PF01497
(Peripla_BP_2)
5 GLY A 118
ALA A 117
LEU A 111
PRO A  87
ILE A  92
None
0.90A 3em4U-2xuzA:
undetectable
3em4U-2xuzA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0j PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA1438


(Thermus
thermophilus)
PF04029
(2-ph_phosp)
6 ARG A 129
GLY A 156
ALA A 155
GLY A 173
VAL A 136
ILE A 138
None
1.08A 3em4U-2z0jA:
undetectable
3em4U-2z0jA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zc0 ALANINE GLYOXYLATE
TRANSAMINASE


(Thermococcus
litoralis)
PF00155
(Aminotran_1_2)
5 GLY A 109
ALA A 110
ILE A 212
GLY A 115
ILE A 258
None
0.93A 3em4U-2zc0A:
undetectable
3em4U-2zc0A:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3abi PUTATIVE
UNCHARACTERIZED
PROTEIN PH1688


(Pyrococcus
horikoshii)
PF03435
(Sacchrp_dh_NADP)
PF16653
(Sacchrp_dh_C)
6 ARG A 342
GLY A 117
ALA A 116
ASP A 115
GLY A  67
ILE A 306
None
NAD  A1001 (-3.6A)
None
None
None
None
1.35A 3em4U-3abiA:
undetectable
3em4U-3abiA:
11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.86A 3em4U-3dbgA:
undetectable
3em4U-3dbgA:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3egj N-ACETYLGLUCOSAMINE-
6-PHOSPHATE
DEACETYLASE


(Vibrio cholerae)
PF01979
(Amidohydro_1)
5 GLY A 241
ALA A 240
ILE A 260
VAL A 228
ILE A 232
None
0.91A 3em4U-3egjA:
undetectable
3em4U-3egjA:
14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f6r FLAVODOXIN

(Desulfovibrio
desulfuricans)
PF00258
(Flavodoxin_1)
5 ALA A 141
ASP A 143
ILE A 120
VAL A  33
ILE A  26
None
0.94A 3em4U-3f6rA:
undetectable
3em4U-3f6rA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbs OXIDOREDUCTASE

(Agrobacterium
fabrum)
PF07992
(Pyr_redox_2)
5 GLY A 284
ALA A  17
ILE A  66
GLY A  22
ILE A   7
None
0.80A 3em4U-3fbsA:
undetectable
3em4U-3fbsA:
14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fo8 TAIL SHEATH PROTEIN
GP18


(Escherichia
virus T4)
PF17481
(Phage_sheath_1N)
5 ASP D 114
ILE D 182
LEU D 178
VAL D 134
ILE D 131
None
0.76A 3em4U-3fo8D:
undetectable
3em4U-3fo8D:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3foa TAIL SHEATH PROTEIN
GP18


(Escherichia
virus T4)
PF04984
(Phage_sheath_1)
PF17481
(Phage_sheath_1N)
5 ASP A 114
ILE A 182
LEU A 178
VAL A 134
ILE A 131
None
0.92A 3em4U-3foaA:
undetectable
3em4U-3foaA:
12.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fqd 5'-3'
EXORIBONUCLEASE 2


(Schizosaccharomyces
pombe)
PF03159
(XRN_N)
5 ASP A 237
ILE A 346
GLY A 334
LEU A 338
VAL A 327
None
0.87A 3em4U-3fqdA:
undetectable
3em4U-3fqdA:
8.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fs2 2-DEHYDRO-3-DEOXYPHO
SPHOOCTONATE
ALDOLASE


(Brucella
melitensis)
PF00793
(DAHP_synth_1)
5 GLY A  75
ASP A  61
ILE A  98
PRO A 109
VAL A 110
None
0.79A 3em4U-3fs2A:
undetectable
3em4U-3fs2A:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gaz ALCOHOL
DEHYDROGENASE
SUPERFAMILY PROTEIN


(Novosphingobium
aromaticivorans)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  43
ILE A  66
GLY A  96
VAL A  37
ILE A  39
None
0.92A 3em4U-3gazA:
undetectable
3em4U-3gazA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
6 ARG A 102
GLY A 107
ALA A 108
ASP A 109
ILE A  59
VAL A  63
None
1.11A 3em4U-3gt7A:
undetectable
3em4U-3gt7A:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhe RIBOSE-5-PHOSPHATE
ISOMERASE A


(Bartonella
henselae)
PF06026
(Rib_5-P_isom_A)
6 ARG A 237
GLY A 105
ALA A 106
ASP A 107
LEU A 234
ILE A 109
None
5RP  A 501 (-3.5A)
None
5RP  A 501 (-2.6A)
None
None
1.08A 3em4U-3hheA:
undetectable
3em4U-3hheA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhe RIBOSE-5-PHOSPHATE
ISOMERASE A


(Bartonella
henselae)
PF06026
(Rib_5-P_isom_A)
6 GLY A 105
ALA A 106
ASP A 107
LEU A 234
PRO A 252
ILE A 109
5RP  A 501 (-3.5A)
None
5RP  A 501 (-2.6A)
None
None
None
1.48A 3em4U-3hheA:
undetectable
3em4U-3hheA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hvm AGMATINE DEIMINASE

(Helicobacter
pylori)
PF04371
(PAD_porph)
5 GLY A 182
ALA A 183
GLY A 148
LEU A   5
ILE A 152
None
0.92A 3em4U-3hvmA:
undetectable
3em4U-3hvmA:
14.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i44 ALDEHYDE
DEHYDROGENASE


(Bartonella
henselae)
PF00171
(Aldedh)
6 ALA A  44
ASP A  43
ILE A   9
LEU A 173
VAL A 143
ILE A  48
None
1.40A 3em4U-3i44A:
undetectable
3em4U-3i44A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ij3 CYTOSOL
AMINOPEPTIDASE


(Coxiella
burnetii)
PF00883
(Peptidase_M17)
5 GLY A 252
ALA A 253
GLY A 258
LEU A 259
ILE A 276
None
0.88A 3em4U-3ij3A:
undetectable
3em4U-3ij3A:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j2n TAIL SHEATH PROTEIN
GP18


(Escherichia
virus T4)
PF04984
(Phage_sheath_1)
PF17481
(Phage_sheath_1N)
PF17482
(Phage_sheath_1C)
5 ASP U 114
ILE U 182
LEU U 178
VAL U 134
ILE U 131
None
0.92A 3em4U-3j2nU:
undetectable
3em4U-3j2nU:
10.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jtm FORMATE
DEHYDROGENASE,
MITOCHONDRIAL


(Arabidopsis
thaliana)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
5 GLY A 136
ALA A 135
LEU A 373
VAL A 103
ILE A 108
None
GOL  A 382 ( 4.3A)
None
None
None
0.89A 3em4U-3jtmA:
undetectable
3em4U-3jtmA:
16.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
PRO A  81
VAL A  82
ILE A  84
None
1.28A 3em4U-3mwsA:
20.0
3em4U-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
VAL A  82
ILE A  84
None
0.39A 3em4U-3mwsA:
20.0
3em4U-3mwsA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
5 GLY A 224
ALA A 225
ASP A 226
VAL A 207
ILE A 261
PO4  A 767 ( 4.6A)
None
None
None
None
0.78A 3em4U-3o8lA:
undetectable
3em4U-3o8lA:
9.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8o 6-PHOSPHOFRUCTOKINAS
E SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00365
(PFK)
5 GLY A 414
ALA A 415
ASP A 416
VAL A 397
ILE A 452
None
0.87A 3em4U-3o8oA:
undetectable
3em4U-3o8oA:
9.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ogz UDP-SUGAR
PYROPHOSPHORYLASE


(Leishmania
major)
PF01704
(UDPGP)
5 GLY A 122
ALA A 121
ASP A 271
ILE A 269
ILE A 167
None
0.87A 3em4U-3ogzA:
undetectable
3em4U-3ogzA:
10.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 419
ALA A 420
ASP A 421
VAL A 402
ILE A 457
None
0.75A 3em4U-3opyA:
undetectable
3em4U-3opyA:
7.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pet PUTATIVE ADHESIN

(Bacteroides
fragilis)
PF10988
(DUF2807)
5 GLY A  50
ALA A  49
ASP A  48
ILE A 116
ILE A  55
PG4  A 251 ( 4.2A)
None
None
None
None
0.94A 3em4U-3petA:
undetectable
3em4U-3petA:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE


(Corynebacterium
glutamicum)
PF00171
(Aldedh)
5 GLY A 285
ALA A 286
ILE A 389
VAL A 396
ILE A 394
GLY  A 285 ( 0.0A)
ALA  A 286 ( 0.0A)
ILE  A 389 ( 0.7A)
VAL  A 396 ( 0.6A)
ILE  A 394 ( 0.7A)
0.85A 3em4U-3r64A:
undetectable
3em4U-3r64A:
11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r9j SEPTUM
SITE-DETERMINING
PROTEIN MIND


(Escherichia
coli)
PF01656
(CbiA)
5 ASP A 230
ALA A 233
ASP A 234
ILE A 211
LEU A 218
None
None
None
ADP  A 261 (-4.6A)
None
0.94A 3em4U-3r9jA:
undetectable
3em4U-3r9jA:
17.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
None
0.75A 3em4U-3t3cA:
18.5
3em4U-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
1.47A 3em4U-3ttpA:
19.6
3em4U-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.51A 3em4U-3ttpA:
19.6
3em4U-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
1.44A 3em4U-3u7sA:
19.9
3em4U-3u7sA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
0.54A 3em4U-3u7sA:
19.9
3em4U-3u7sA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
None
0.69A 3em4U-3uhlA:
16.2
3em4U-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.51A 3em4U-3uhlA:
16.2
3em4U-3uhlA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aip FE-REGULATED PROTEIN
B


(Neisseria
meningitidis)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 GLY A 165
ALA A 166
ASP A 118
GLY A 159
ILE A 168
None
0.91A 3em4U-4aipA:
undetectable
3em4U-4aipA:
8.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2o YMDB
PHOSPHODIESTERASE


(Bacillus
subtilis)
PF13277
(YmdB)
5 GLY A  59
ALA A  60
ASP A  61
LEU A  25
VAL A   9
None
0.85A 3em4U-4b2oA:
undetectable
3em4U-4b2oA:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2o YMDB
PHOSPHODIESTERASE


(Bacillus
subtilis)
PF13277
(YmdB)
5 GLY A  59
ALA A  60
ASP A  61
VAL A   9
ILE A  36
None
0.91A 3em4U-4b2oA:
undetectable
3em4U-4b2oA:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f4o HAPTOGLOBIN

(Sus scrofa)
PF00089
(Trypsin)
5 GLY C 129
ALA C 130
ILE C 133
VAL C 177
ILE C 191
None
0.92A 3em4U-4f4oC:
undetectable
3em4U-4f4oC:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iv9 TRYPTOPHAN
2-MONOOXYGENASE


(Pseudomonas
savastanoi)
PF01593
(Amino_oxidase)
5 GLY A  95
ALA A  96
ILE A  48
GLY A  75
ILE A 274
FAD  A 601 (-3.9A)
FAD  A 601 (-3.4A)
None
None
None
0.92A 3em4U-4iv9A:
undetectable
3em4U-4iv9A:
12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k5u VARIABLE LYMPHOCYTE
RECEPTOR


(Petromyzon
marinus)
no annotation 5 GLY B  63
GLY B  18
PRO B  25
VAL B  24
ILE B  42
None
0.92A 3em4U-4k5uB:
undetectable
3em4U-4k5uB:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kq6 6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE


([Candida]
glabrata)
PF00885
(DMRL_synthase)
6 GLY A  38
ALA A  39
ILE A 122
GLY A 124
VAL A  55
ILE A  22
None
1.44A 3em4U-4kq6A:
undetectable
3em4U-4kq6A:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n06 CRISPR-ASSOCIATED
ENDONUCLEASE CAS1 1


(Archaeoglobus
fulgidus)
PF01867
(Cas_Cas1)
6 GLY A  13
ALA A  51
ASP A  50
GLY A  17
LEU A  18
VAL A  60
None
1.41A 3em4U-4n06A:
undetectable
3em4U-4n06A:
14.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
RIT  A 500 (-3.2A)
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.34A 3em4U-4njvA:
20.7
3em4U-4njvA:
84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1e DIHYDROPTEROATE
SYNTHASE DHPS


(Desulfitobacterium
hafniense)
PF00809
(Pterin_bind)
5 ASP A 170
GLY A 172
ALA A 173
PRO A 131
ILE A 165
None
0.84A 3em4U-4o1eA:
undetectable
3em4U-4o1eA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pv4 PROLINE
AMINOPEPTIDASE P II


(Yersinia pestis)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 ARG A 219
GLY A 260
ALA A 259
ASP A 258
ILE A 213
None
None
None
MG  A 501 ( 2.0A)
None
0.81A 3em4U-4pv4A:
undetectable
3em4U-4pv4A:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u1r ATP-DEPENDENT
6-PHOSPHOFRUCTOKINAS
E, PLATELET TYPE


(Homo sapiens)
PF00365
(PFK)
5 GLY A 233
ALA A 234
ASP A 235
VAL A 216
ILE A 270
PO4  A 802 (-4.0A)
None
PO4  A 802 ( 4.6A)
None
None
0.90A 3em4U-4u1rA:
undetectable
3em4U-4u1rA:
10.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x0l HAPTOGLOBIN

(Homo sapiens)
PF00089
(Trypsin)
5 GLY C 188
ALA C 189
ILE C 192
VAL C 236
ILE C 250
None
0.93A 3em4U-4x0lC:
undetectable
3em4U-4x0lC:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xvo L,D-TRANSPEPTIDASE

(Mycolicibacterium
smegmatis)
PF03734
(YkuD)
5 ASP A 107
ALA A  91
ASP A  88
ILE A  84
PRO A  63
None
0.89A 3em4U-4xvoA:
undetectable
3em4U-4xvoA:
20.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 ARG A  10
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.57A 3em4U-4ydfA:
13.0
3em4U-4ydfA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yj1 UNCHARACTERIZED
PROTEIN


(Trypanosoma
brucei)
PF09818
(ABC_ATPase)
5 GLY A 619
ALA A 618
ILE A 649
GLY A 652
LEU A 655
None
0.81A 3em4U-4yj1A:
undetectable
3em4U-4yj1A:
10.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z9n AMINO ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN


(Brucella ovis)
PF00497
(SBP_bac_3)
5 GLY A 125
ALA A 126
ILE A 109
LEU A 121
ILE A 128
None
0.86A 3em4U-4z9nA:
undetectable
3em4U-4z9nA:
15.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
1.10A 3em4U-5b18A:
18.2
3em4U-5b18A:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5elz TYPE II PANTOTHENATE
KINASE


(Staphylococcus
aureus)
PF03630
(Fumble)
5 GLY A  51
ALA A   7
ILE A  14
GLY A   4
ILE A  57
None
0.89A 3em4U-5elzA:
undetectable
3em4U-5elzA:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i20 UNCHARACTERIZED
PROTEIN


(Starkeya
novella)
PF00892
(EamA)
5 GLY A 277
ALA A 278
LEU A 129
PRO A 248
VAL A 249
None
0.88A 3em4U-5i20A:
undetectable
3em4U-5i20A:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mg3 PROTEIN TRANSLOCASE
SUBUNIT SECD


(Escherichia
coli)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
PF13721
(SecD-TM1)
6 ARG D 439
ILE D 430
GLY D 274
LEU D 273
VAL D 248
ILE D 256
None
1.49A 3em4U-5mg3D:
undetectable
3em4U-5mg3D:
10.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n2p TRYPTOPHAN SYNTHASE
ALPHA CHAIN


(Sulfolobus
solfataricus)
no annotation 5 GLY A 205
ALA A 206
ASP A 207
LEU A 181
VAL A 159
None
None
None
None
CL  A 303 ( 4.4A)
0.88A 3em4U-5n2pA:
undetectable
3em4U-5n2pA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4c PROLYL
OLIGOPEPTIDASE


(Galerina
marginata)
no annotation 6 ALA A 598
ILE A 655
GLY A 580
PRO A 640
VAL A 588
ILE A 587
None
1.36A 3em4U-5n4cA:
undetectable
3em4U-5n4cA:
7.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
None
1.42A 3em4U-5t2zA:
20.1
3em4U-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
None
0.41A 3em4U-5t2zA:
20.1
3em4U-5t2zA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tic ACYL-COA
THIOESTERASE I


(Escherichia
coli)
PF13472
(Lipase_GDSL_2)
6 ASP A  74
GLY A  71
ASP A   9
ILE A  42
GLY A  50
LEU A  51
None
1.23A 3em4U-5ticA:
undetectable
3em4U-5ticA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve3 BPPRF

(Paraburkholderia
phytofirmans)
no annotation 5 GLY B  88
ALA B  89
ASP B  90
VAL B  59
ILE B  80
None
0.78A 3em4U-5ve3B:
undetectable
3em4U-5ve3B:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm2 ALCOHOL
DEHYDROGENASE


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 237
ALA A 238
ASP A 239
VAL A 199
ILE A 173
None
0.80A 3em4U-5vm2A:
undetectable
3em4U-5vm2A:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b92 U6 SMALL NUCLEAR RNA
(ADENINE-(43)-N(6))-
METHYLTRANSFERASE


(Homo sapiens)
no annotation 5 GLY A 121
ALA A 122
GLY A 106
VAL A 157
ILE A 155
None
0.91A 3em4U-6b92A:
undetectable
3em4U-6b92A:
18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bma INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE


(Campylobacter
jejuni)
no annotation 5 ALA A 237
ASP A 236
ILE A 184
GLY A 186
ILE A  54
None
0.81A 3em4U-6bmaA:
undetectable
3em4U-6bmaA:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dkh L-IDONATE
5-DEHYDROGENASE
(NAD(P)(+))


(Escherichia
coli)
no annotation 5 GLY A 177
ILE A 197
GLY A 210
LEU A 209
ILE A 185
None
0.89A 3em4U-6dkhA:
undetectable
3em4U-6dkhA:
18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eic MYCOBACTERIUM
TUBERCULOSIS
MONOGLYCERIDE LIPASE


(Mycobacterium
tuberculosis)
no annotation 6 ALA C 199
ASP C  80
GLY C 155
LEU C 154
VAL C 192
ILE C 196
None
1.42A 3em4U-6eicC:
undetectable
3em4U-6eicC:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A  13
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.60A 3em4U-6fivA:
15.5
3em4U-6fivA:
29.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6grw -

(-)
no annotation 5 ASP A 414
ILE A 287
GLY A 265
LEU A 269
VAL A 196
None
0.91A 3em4U-6grwA:
undetectable
3em4U-6grwA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
0.83A 3em4U-6upjA:
18.3
3em4U-6upjA:
48.48